Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT00004922 · COMPLETED

Trial details

NCT number: NCT00004922
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma of Unknown Primary Neuroendocrine Carcinoma Neuroendocrine Carcinoma of the Skin

Start date: 1999-06-01
Primary completion: 2002-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.